Inspire Medical downgraded to Sector Weight from Overweight at KeyBanc

KeyBanc downgraded Inspire Medical (INSP) to Sector Weight from Overweight without a price target The firm says its previous share thesis is “impaired” with the magnitude of the company’s 2025 guidance revisions. Inspire’s near- to mid-term visibility “appears incrementally uncertain” due to several new and existing headwinds, the analyst tells investors in a research note. KeyBanc adds that the company now plans to increase direct-to-consumer spend at a rate above expected sales growth.